2. Stedman C. Herbal hepatotoxicity. Semin Liver Dis. 2002. 22:195–206.
Article
3. Stickel F, Egerer G, Seitz HK. Hepatotoxicity of botanicals. Public Health Nutr. 2000. 3:113–124.
Article
4. Zimmerman HJ. Hepatotoxicity. Dis Mon. 1993. 39:675–787.
5. Benninger J, Schneider HT, Schuppan D. Acute hepatitis induced by greater celandine(
Chelidonium majus). Gastroenterology. 1999. 117:1234–1237.
Article
6. De Berardinis V, Moulis C, Maurice M, Beaune P, Pessayre D, Loeper J, et al. Human microsomal epoxide hydrolase is the target of germander-indued autoantibodies on the surface of human hepatocytes. Mol Pharmacol. 2000. 58:542–551.
Article
7. Watkins RE, Maglich JM, Moore LB, Noble SM, Davis-Searles PR, Redinbo MR, et al. 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry. 2003. 18:1430–1438.
8. Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev. 2004. 36:57–104.
Article
9. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest. 1998. 102:1016–1023.
Article
10. Izzo AA. Drug interactions with St. John's Wort(Hypericum
perforatum); a review of the clinical evidence. Int J Clin Pharmacol Ther. 2004. 42:139–148.
Article
11. Khojasteh-Bakht SC, Chen W, Konigs LL, Peter RM, Nelson SD. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s; evidence for formation of a furan epoxide. Drug Metab Dispos. 1999. 27:574–580.
12. Baily DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther. 2000. 68:468–477.
Article
13. Wang DG, Casciano CN, Clement RP, Johnson WW. Inhibition of P-glycoprotein transport function by grapefruit juice psoralen. Pharm Res. 2001. 18:432–438.
14. Tanaka K, Kean EA, Johnson B. Jamaican vomiting sickness. Biochemical investigation of two cases. N Engl J Med. 1976. 295:461–467.
15. Zimmerman HJ, Lewis JH. Chemical-and toxin-induced hepatotoxicity. Gastroenterol Clin North Am. 1995. 24:1027–1045.
16. Wong WM, Wu PC, Yuen MF, Cheng CC, Yew WW, Lai CL, et al. Chronic hepatitis B carriers have more frequent and more severe liver injury with antituberculosis drugs. Gastroenterology. 1988. 114:A1366.
Article
17. Castot A, Larrey D. Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance. Gastroenterol Clin Biol. 1992. 16:916–922.
18. Lee DS, Baek JT, Kim JS, et al. A case of toxic hepatitis caused by the Chinese diet food. Korean J Med. 2003. 65:689–692.
19. Kanda T, Yokosuka O, Tada M, Kurihara T, Yoshida S, Saisho H, et al. N-nitroso-fenfluramine hepatotoxicity resembling chronic hepatitis. J Gastroenterol Hepatol. 2003. 18:999–1000.
Article
20. Favreau JT, Ryu ML, Braunstein G, Orshansky G, Park SS, Coody GL, et al. Severe hepatotoxicity associated with the dietary supplement lipokinetix. Ann Intern Med. 2002. 136:590–595.
Article
21. Kaplowitz N. Hepatotoxicity of herbal remedies: insights into intricacies of plant-animal warfare and cell death. Gastroenterology. 1997. 113:1408–1412.
Article
22. Nozawa T, Sugiura S, Nakajima M, Goto A, Yokoi T, Tamai I, et al. Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity. Drug Metab Dispos. 2004. 32:291–294.
Article
23. Haouzi D, Lekehal M, Moreau A, Moulis C, Feldmann G, Pessayre D, et al. Cytochrome P450-gene-rated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes. Hepatology. 2000. 32:303–311.
Article
24. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Kroemer G, et al. Mitochondrial control of nuclear apoptosis. J Exp Med. 1996. 183:1533–1544.
Article
25. Thatte U, Bagadey S, Dahanukar S. Modulation of programmed cell death by medicinal plants. Cell Mol Biol. 2000. 46:199–214.
26. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. et al. Intracellular adenosine triphosphate(ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 1997. 185:1481–1486.
Article
27. Huxtable RJ. New aspects of the toxicology and pharmacology of pyrrolizidine alkaloids. Gen Pharmacol. 1979. 10:159–167.
Article
28. Bras G, Jelliffe DB, Stuart KL. Veno-occlusive disease of liver with nonportal type of cirrhosis occuring in Jamaica. Arch Path. 1954. 57:285–300.
29. Roulet M, Laurini R, Rivier L, Calame A, et al. Hepatic venoocclusive disease in newborn infant of a woman drinking tea. J Pediatr. 1988. 112:433–436.
Article
30. Melchart D, Linde K, Weidenhammer W, Hager S, Shaw D, Bauer R. Liver enzyme elevation in patients treated with traditional Chinese medicine. JAMA. 1999. 282:28–29.
Article
31. Chun WJ, Yoon BG, Kim NI, Lee G, Yang CH, Suh JI, et al. A clinical study of patients with acute liver injury caused by herbal medication in Gyeong-ju area. Korean J Med. 2002. 63:141–150.
32. Woolf GM, Petrovic LM, Rojter SE, Wainwright S, Villamil FG, Vierling JM, et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med. 1994. 121:729–735.
Article
33. McRae CA, Agrawal K, Mutimer D, Bassendine HF. Hepatitis associated with Chinese herbs. Eur J Gastroenterol Hepatol. 2002. 14:559–562.
Article
34. Yoshida EM, McLean CA, Cheng ES, Blanc PD, Somberg KA, Lake JR, et al. Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol. 1996. 91:2647–2648.
35. Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol. 1997. 37:334–350.
Article
36. Lee JH, Lee HY, Koh KC, et al. Drug induced liver disease caused by ingestion of Dictamnus dasycarpus. Korean J Gastroenterol. 1998. 31:251–257.
37. Nadir A, Agrawal S, King PD, Marshall JB, et al. Acute hepatitis associated with the use of a Chinese product, Ma-huang. Am J Gastroenterol. 1996. 91:1436–1438.
38. Park GJ, Mann SP, Ngu MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from
Polygonum multiflorum. J Gastroenterol Hepatol. 2001. 16:115–117.
Article
39. Cho JC, Lee HK, Choi JW, Lee YS, Jung YW, Seo DJ. A case of acute hepatitis related to the Chinese Medicine Ho-Shou-Wu. Korean J Med. 1999. 56:753–756.
40. Young CY. Neonatal hyperbilirubinemia in Chinese. Trop Geogr Med. 1973. 25:151.
41. Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. Acute hepatitis induced by greater celandine(
Chelidonium majus). Gastroenterology. 1999. 117:1234–1234.
Article